Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $65.9 million.

  • Orthofix Medical's Cash & Current Investments rose 10257.42% to $65.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.9 million, marking a year-over-year increase of 10257.42%. This contributed to the annual value of $85.7 million for FY2024, which is 12707.84% up from last year.
  • As of Q3 2025, Orthofix Medical's Cash & Current Investments stood at $65.9 million, which was up 10257.42% from $68.7 million recorded in Q2 2025.
  • Orthofix Medical's 5-year Cash & Current Investments high stood at $94.6 million for Q1 2021, and its period low was $28.9 million during Q2 2024.
  • Over the past 5 years, Orthofix Medical's median Cash & Current Investments value was $59.5 million (recorded in 2022), while the average stood at $58.4 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first crashed by 5374.58% in 2021, then surged by 13795.82% in 2025.
  • Quarter analysis of 5 years shows Orthofix Medical's Cash & Current Investments stood at $87.8 million in 2021, then tumbled by 42.29% to $50.7 million in 2022, then decreased by 25.53% to $37.8 million in 2023, then soared by 127.08% to $85.7 million in 2024, then decreased by 23.08% to $65.9 million in 2025.
  • Its last three reported values are $65.9 million in Q3 2025, $68.7 million for Q2 2025, and $60.5 million during Q1 2025.